MARCH BIOSCIENCES INC

Transforming Patient Care by Unlocking New Target Spaces

Houston, United States · Founded 2024 · $32.4M raised

Headquarters
Houston, Texas
Employees
1–10
Founded
2024
Business Model
B2B
Website
march.bio
Total Funding
$32.4M
Last Round
$28.4M Series AOct 2024
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

March Biosciences is a Houston, Texas clinical-stage cell therapy company focused on developing CAR-T cell therapies for challenging hematological cancers. Its lead asset, MB-105, is a CD5-targeted CAR-T therapy in Phase 2 clinical trials for relapsed/refractory T-cell lymphoma and has received FDA Regenerative Medicine Advanced Therapy (RMAT) designation. The company was launched from Baylor College of Medicine's Center for Cell and Gene Therapy and has raised over $53 million to date.

Summary

MARCH BIOSCIENCES INC is a Biotech company based in Houston, United States, founded in 2024. It has raised $32.4M in total across 2 rounds, most recently a $28.4M Series A round in Oct 2024. Investors include Mission BioCapital, 4BIO Capital and Cancer Focus Fund.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AOct 2024
$28.4M

Sign up to see all 2 events

Funding: Seed through Series A. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MARCH BIOSCIENCES INC on Indexed.vc
<a href="https://indexed.vc/companies/march-biosciences-inc"><img src="https://indexed.vc/api/badge/company/march-biosciences-inc" alt="MARCH BIOSCIENCES INC on Indexed.vc" width="260" height="76" /></a>